Everolimus(Afinitor)

Release date: 2026-01-05 14:27:51     Recommended: 2

Indicated for the treatment of advanced hormone receptor-positive, HER2-negative breast cancer; neuroendocrine tumors of pancreatic, gastrointestinal, and pulmonary origin; advanced renal cell carcino